The strong resemblance of histology, tumor grade and Ki-67 immunoreactivities between the tumors arising from the PyVT-iPSC clones and the tumors arising within the PyVT transgenics suggest that we have successfully used the iPSC clones as transgenic surrogates. Here, MKI67 is linked to neoplasm.